Pancreatin-Delayed Release Pellets-Suitable for 10000, 25000, 40000 iu unit Caps (Creon)
- Release pattern and comparative study done with innovator
- MKPPL product advantages include:
- Smaller size of pellets.
- Spherical shaped pellets compared to the innovator Creon.
- Higher drug loading possible to meet 50,000 iu lipase activity.
Offer complete technical package for registrations in all regulated/semi regulated markets.
Share
Additional information
| Percentage | 70% |
|---|---|
| Release Type | Delayed Release |
| Target Formulations | Capsules |
| Routes of administration | Oral |
| Documentation Available: | Technical Package |
